Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation

BACKGROUND/AIMS: Limited information is available regarding patient survival after sorafenib discontinuation in patients with hepatocellular carcinoma (HCC). Thus, we developed and validated a novel survival prediction model. METHODS: Clinical data from 409 patients with HCC who stopped taking soraf...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Won, Kim, Hyun Soo, Kim, Seung Up, Kim, Do Young, Kim, Beom Kyung, Park, Jun Yong, Ahn, Sang Hoon, Jeon, Mi Young, Heo, Ja Yoon, Park, Soo Young, Lee, Yu Rim, Jang, Sun Kyung, Lee, Su Hyun, Jang, Se Young, Tak, Won Young, Han, Kwang-Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593332/
https://www.ncbi.nlm.nih.gov/pubmed/28651299
http://dx.doi.org/10.5009/gnl16391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593332/
https://www.ncbi.nlm.nih.gov/pubmed/28651299
http://dx.doi.org/10.5009/gnl16391

Ejemplares similares